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Abbreviations 
EcSC - endometriotic stromal cells  
EMT - epithelial-mesenchymal transition  
EnSC - endometrial stromal cells  
FACS - fluorescence-activated cell sorting 
FC - fold change 
LCM - laser capture microdissection 
UTR – untranslated region  
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ABSTRACT 
In order to uncover miRNA changes in endometriosis pathogenesis, both endometriotic 
lesions and endometrial biopsies, as well as stromal and epithelial cells isolated from these 
tissues have been investigated and a large number of dysregulated miRNAs has been reported. 
However, the concordance between the result of different studies has remained small. One 
potential explanation for limited overlap between the proposed disease-related miRNAs could 
be the heterogeneity in tissue composition, as some studies have compared highly 
heterogeneous whole-lesion biopsies with endometrial tissue, some have compared the 
endometrium from patients and controls, and some have used pure cell fractions isolated from 
lesions and endometrium. This review focuses on the results of published miRNA studies in 
endometriosis to reveal the potential impact of tissue heterogeneity on the discovery of 
disease-specific miRNA alterations in endometriosis. Additionally, functional studies that 
explore the roles of endometriosis-involved miRNAs are discussed.  
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1. Introduction 
Although several hints about biological processes leading to endometriosis development have 
emerged in the era of high-throughput studies, we still lack in-depth knowledge on the exact 
molecular basis of the disease development. Without unravelling all the components that play 
a role in different molecular processes of endometriosis pathophysiology, it is impossible to 
solve the mystery of this disease and to find a definite cure. 
In endometriosis, the female internal reproductive system and other pelvic organs are 
affected by endometriotic lesions growing on the surface of pelvic cavity organs (ovaries, 
uterus and fallopian tubes), ligaments (uterosacral ligaments, broad and round ligaments), 
recto-uterine pouch and/or ovarian fossa. During laparoscopic surgery, lesions are removed 
and these tissue samples are often used in endometriosis studies to find disease-specific 
changes. However, the cellular composition of whole-lesion biopsies is heterogeneous and 
contains cells from surrounding tissue (e.g. peritoneal tissue, ovarian components, traces of 
uterine wall etc.), inflammatory cells, and endometrial stromal and epithelial cells in variable 
proportions. Therefore, the heterogeneity of endometriotic lesion biopsies is a real challenge 
in endometriosis research, as the molecular signature of endometrial cells in lesions could be 
masked by the surrounding tissue leading to inconsistent or wrongly interpreted results.   
microRNAs (miRNAs) are small (typically 22 nucleotides in size) non-coding RNA 
molecules that regulate target mRNA expression. The most common mechanism of action 
involves an interaction of the so-called seed-sequence of the miRNA with the 3’UTR of target 
mRNAs, resulting in translational inhibition, mRNA degradation and/or destabilisation [1]. 
Therefore, changes in the dynamic balance between miRNAs and their target mRNAs may 
lead to alterations in normal physiological status of the tissues and initiate pathological 
processes. The knowledge about the miRNA signatures in tissues is constantly evolving and 
curated in databases presenting tissue-specific miRNA profiles (e.g. miRmine - Human 
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miRNA Expression Database [2], miRGator [3], the Human miRNA Tissue Atlas [4]), 
showing that miRNA levels in different tissues are highly variable. Furthermore, tissue-
specific miRNA expression levels are also influenced by normal physiological processes, 
such as endocrine influences throughout the menstrual cycle in endometrium [5].  
A number of miRNAs have been reported as dysregulated in endometrium and lesions 
of endometriosis patients [5–7]. However, different studies have not reached a consensus on 
which particular miRNAs are most relevant in endometriosis, as dysregulated miRNAs 
reported in one study are only occasionally confirmed by others. In our previous miRNA 
study [8], we showed that miRNA profile of peritoneal endometriotic lesion biopsies is more 
similar to healthy peritoneal tissues rather than to endometrium of the same women. We also 
showed that endometriotic lesion biopsies contain only a small fraction of endometrium-
specific cells and various proportions of non-diseased tissue that can mask the disease-
specific miRNA changes in endometriotic lesions. Therefore, we suggest that one potential 
explanation for limited overlap between the proposed disease-related miRNAs in 
endometriosis is heterogeneity in tissue composition, as some studies have compared whole-
lesion biopsies with endometrial tissue, some have analysed endometrial tissue from patients 
and controls, and some have used pure cell fractions isolated from lesions and endometria 
(Figure 1).  
In this review, we focus on the results of published miRNA studies in endometriosis to 
discuss the potential impact of tissue heterogeneity on the discovery of disease-specific 
miRNA alterations in endometriosis. We believe that the question about the tissue biopsy 
heterogeneity needs to be highlighted and not only in endometriosis molecular research but 
also in many other diseases where heterogeneous tissue biopsies have been used to find 
disease specific alterations. Also, we give an overview of functional studies performed to find 
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out the precise roles of miRNAs in endometriosis pathogenesis, and propose future directions 
in endometriosis miRNA research. 
 
 
Figure 1. Origin of tissue heterogeneity in endometriosis miRNA studies. Peritoneal lesions 
and endometriomas contain only a small fraction of endometrium-specific cells leading to the 
heterogeneous miRNA signature (brown colour in endometrioma histological section 
indicates CD10+ endometrial stromal cells that surround the endometrial epithelial glandular 
structure).  
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2. High tissue/cellular heterogeneity - miRNA expression profiling studies in 
endometriotic lesions 
A large number of published studies have evaluated associations between miRNAs and 
endometriosis by comparing miRNA expression levels in endometrium (consisting mostly of 
epithelial and stromal cells) to lesions that additionally include surrounding tissue (peritoneal 
or ovarian tissue) in variable proportions (Table 1). Both hypothesis-driven studies, 
investigating dysregulation of particular miRNAs [9–14] and high-throughput studies [8,15–
20] have been used to find lesion-specific disease-related changes in miRNA levels (Table 1). 
More detailed information about the results of these studies and the potential roles of 
dysregulated miRNAs is available in recently published excellent reviews [7,21]. A closer 
look at high-throughput studies, where the full spectrum of miRNAs expressed in tissues were 
studied [8,15–20], indicates that the number of dysregulated miRNAs potentially associated 
with endometriosis pathogenesis is relatively variable (5 to 156 miRNAs per study). Moreover, 
in perspective of tissue type heterogeneity, three of these studies investigated endometriomas 
[16,17,20], two endometriotic lesions with no specification [18,19] and one study included 
peritoneal lesions [15]. Venn analysis (data not shown) of all found differentially expressed 
miRNAs between lesions and endometrium (Fold Change - FC at least 1.5), irrespective of 
the analysed lesion location and without taking into account the miRNA strand from which it 
was derived (-5p or -3p), showed only a small overlap between the result of these six studies. 
Fourteen miRNAs were significantly differentially expressed in at least three studies (Table 2) 
and only miR-200b was found to be differentially expressed in all six studies. However, it 
should be pointed out that none of the aforementioned high-throughput studies included 
information on whether multiple testing correction was implemented in data analysis, and 
therefore some of the reported associations may also be false-positive. 
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Table 1. High tissue/cellular heterogeneity - miRNA studies comparing endometriotic lesions to endometrium. 
 
Candidate miRNA studies 
miRNAs 
Studied tissues 
Menstrual cycle 
phase* 
References 
Patients (n) Controls (n) 
miR-15b, miR-16, miR-17-5p, 
miR-20a, miR-21, miR-125a, 
miR-221 and miR-222 
Endometriomas (n=41) 
Endometrium (n=41) 
Endometrium (n=38) P/S [9] 
miR-191 Endometriomas (n=12) Healthy ovaries (n=12) ND [10] 
miR-451 
Peritoneal lesions and 
endometriomas (n=43) 
Endometrium (n=30) 
- ND/M/P/S [11] 
miR-23a and miR-23b 
Endometriomas (n=23) 
Endometrium (n=23) 
Endometrium (n=15) ND [12] 
miR-29a, miR-29b and miR-
29c 
Lesions (n=20)  
Endometrium (n=20) 
Endometrium (n=10) P [13] 
miR-143, miR-145 
Endometriomas (n=22) 
Endometrium (n=13) 
Endometrium (n=22) P/S [14] 
High-throughput studies  
High-throughput 
methodology 
Studied tissues  
Menstrual cycle 
phase 
References 
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*M - menstrual P -proliferative, S - secretory, I - interval, ND - menstrual cycle phase is not determined 
  
Patients (n) Controls (n) 
Custom-made microarray  
Peritoneal lesions (n=7)  
Endometrium (n=7) 
- P/S [15] 
Custom-made microarray 
Endometriomas (n=3)  
Endometrium (n=3) 
- P [16] 
Illumina next-generation 
sequencing  
Endometriomas (n=10) Endometrium (n=9) P/S/I [17] 
miRCURY LNA™ microRNA 
Array (v. 14.0; Exiqon) 
Lesions (n=3) 
Endometrium (n=3)  
Endometrium (n=3) ND [18] 
Illumina next-generation 
sequencing 
Peritoneal lesions (n=5) 
Peritoneum (n=4)  
Endometrium (n=2) 
- 
 
P/S [8] 
Affymetrix GeneChip miRNA 
array 
Lesions (n=5) Endometrium (n=5) ND [19] 
Affymetrix GeneChip miRNA 
2.0 Array  
Endometriomas (n=3)  
Endometrium (n=7) 
Endometrium (n=5) P/S [20] 
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Table 2. Common miRNAs found to be differentially regulated in endometriotic lesions compared to 
eutopic endometria. 
miRNA 
Number of 
studies (n) 
Upregulated/downregulated 
in lesion 
Reference 
 
miR-200b 6 Downregulated [15–20] 
miR-145 4 Upregulated [15,16,19,20] 
miR-196b 4 Downregulated [15,16,18,20] 
miR-200c 4 Downregulated [16–18,20] 
miR-200a 4 Downregulated [15–17,20] 
miR-183 3 Downregulated [16,18,20] 
miR-202 3 Upregulated [16,18,20] 
miR-141 3 Downregulated [15,17,20] 
miR-34c 3 Downregulated [15,17,20] 
miR-100 3 Upregulated [15–17] 
miR-375 3 Upregulated [16,17,20] 
miR-1 3 Upregulated [15,16,20] 
miR-365 3 Upregulated/downregulated [15,16,20] 
miR-29c 3 Upregulated [15,16,20] 
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Furthermore, although the overlap between studies is as scarce as it is, even so it may be 
overestimated as nomenclature of miRNAs in these studies is not uniform and not all studies 
have referred to the examined miRNAs using the strand-specifying -3p and -5p suffixes or 
other identifiers (e.g. miRBase MIMAT accession number or oligonucleotide sequence). The 
importance of proper miRNA referring has previously been accentuated [7], as the expression 
levels of miRNAs generated either from -5p or -3p arm of the precursor may vary not only 
between different tissues/cells but also in health and disease [22]. 
The most frequently reported differentially expressed miRNA, miR-200b, belongs to 
the miR-200 family that could easily be linked to endometriosis pathogenesis because of 
involvement in cell migration and epithelial-mesenchymal transition (EMT). A 
comprehensive literature review concerning EMT, basic cellular pathways and its importance 
in endometriosis has been published recently [23]. Briefly, the miR-200 family members 
target a complex network of transcription regulators like ZEB1 and ZEB2 (E-box-binding 
transcription factors 1 and 2, respectively), which are transcriptional repressors for E-
cadherin. The overexpression of miR-200 family members results in decreased expression of 
ZEB1/ZEB2 and increased expression of E-cadherin, which is required for maintaining the 
epithelial nature of cells [24]. The epithelial cell plasticity is controlled by an autocrine TGF-
β/ZEB/miR-200 signalling network [25] and by the Wnt/β-catenin pathway (reviewed in 
[23]). During the EMT process, which supposedly occurs in the pathogenesis of 
endometriosis, epithelial cells lose their specific features and integrity, and acquire 
mesenchymal characteristics, leading to increased cell invasion and migration [24]. All 
aforementioned miRNA studies in endometriosis have confirmed significant downregulation 
of miR-200b in endometriomas (~2-fold) and peritoneal lesions (2.8-fold) compared to 
endometrium. Four studies have also reported downregulation of other miR-200 family 
members miR-200a and miR-200c, and three studies downregulation of miR-141 in lesions 
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(Table 2). Although all studies in endometriotic lesions have associated miR-200 family 
members to disease pathogenesis, we have shown that in healthy endometrium miR-200a, 
miR-200b and miR-141 are highly expressed in epithelial cells, indicating the cell type-
specific expression pattern of these miRNAs [8]. Therefore, it is possible that the reported 
seemingly lower expression of miR-200 family members in endometriotic lesions reflects the 
smaller proportion of epithelial cells in lesions rather than is associated with disease 
pathogenesis. Thus, the true relevance of miR-200 family in endometriosis pathogenesis 
needs to be confirmed in the future by comparing pure populations of eutopic and ectopic 
endometrial epithelial cells. Interestingly, a very recent study investigating miRNA 
expression in fluorescence-activated cell sorting (FACS) isolated eutopic endometrial cells of 
patients with and without endometriosis [26] showed higher expression of miR-200b in 
stromal cells of patients compared to controls but there was no difference in miR-200b 
expression in respective epithelial cells (the results of this study are more thoroughly 
discussed in Section 4). 
The second miRNA commonly found upregulated in endometriotic lesions is miR-145 
(miR-145-5p [15,16,19] and miR-145-3p [20]). This miRNA promotes apoptosis in growing 
cancer cells and inhibits cancer cell invasion and metastasis (reviewed in [27]); however, the 
importance of miR-145 in colon cancer pathogenesis has been recently questioned [28]. miR-
145 is highly expressed in mesenchymal cells such as fibroblasts and smooth muscle cells, 
and not in colon cancer or healthy colon epithelial cells; therefore, the lower expression in 
cancer tissue compared to healthy colon merely reflects the differences in cellular 
composition of tissues and not miR-145 dysregulation in cancer cells [28]. The situation may 
be similar in endometriosis, as endometriotic lesion biopsies contain a mixture of different 
cells, including cells from surrounding tissue (e.g. ovarian stroma and peritoneal 
mesenchymal cells) that are not present in eutopic endometrium, and thus we cannot exclude 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
12 
 
that the higher miR-145 level in lesions just reflects the cellular heterogeneity of the tissue 
sample. Still, in vitro studies using endometriotic and endometrial stromal cells have revealed 
a role for miR-145 in the regulation of invasive growth and a stem cell phenotype, as will be 
discussed in Section 5.1 [29].  
The third most commonly dysregulated miRNA in lesions is miR-196b, with a 
genomic location between the HOXA9 and HOXA10 genes. It should be pointed out that miR-
196 family miRNAs, miR-196a and miR-196b, target many genes from the HOX cluster e.g. 
HOXA5, HOXB7, HOXB8, HOXC8 and HOXA10. The latter has been well described in the 
regulation of the endometrial function and there is clear evidence that the pattern of HOXA10 
expression depends on menstrual cycle phase, with a peak expression during the window of 
implantation [30]. Considering the role of miR-196b in tissue vascularization and wound 
healing in response to injury or other pathological conditions [31], and also its possible role in 
normal endometrial physiology, this miRNA has good potential to be related to endometriosis 
pathogenesis or endometriosis-associated infertility. How the magnitude of vascularisation in 
lesions and endometrium, and the menstrual cycle phase could influence the levels of miR-
196b, needs to be clarified in further studies.  
Taken together, although the miRNA studies in whole lesion biopsies have brought 
out some promising miRNAs that could be involved in endometriosis pathogenesis, the 
question about the impact of cellular heterogeneity on these findings remains. The remarkably 
higher cellular heterogeneity of lesions compared to endometrium may have considerable 
effect on the detection rate of differentially expressed miRNAs. To overcome this issue, 
future studies looking for differences in miRNA levels should focus on the isolation and 
analysis of the endometrium-specific cells inside the lesions instead of using whole lesion 
biopsies. Possible approaches to achieve this goal are described in the next section (Section 
2.1). 
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2.1 Possible approaches to diminish cellular heterogeneity in endometriosis studies 
 
Currently, one of the major challenges in endometriosis miRNA research is related to the 
isolation of specific cell-types from tissue specimens, as there is still no ideal methodology 
for obtaining pure populations of endometrial cells without cell culturing. Although miRNAs 
can be successfully isolated from histological tissue sections by laser capture microdissection 
(LCM) technique and isolated miRNAs are suitable for high-throughput analyses [32,33], the 
popularity of this methodology in endometriosis miRNA research has remained small. 
Though this methodology has been implemented to detect DNA aberrations [34,35] and gene 
expression alterations [36] in endometriosis, there are still no studies using LCM-isolated 
endometriotic cells to explore the endometriosis miRNome. The small interest of using LCM 
for isolation of specific cell populations could be related to the complexity and availability of 
this methodology.  
The other possibility is to use combinations of fluorescently labelled antibodies against cell 
surface markers (for example, CD13 and CD10 have previously been shown to be markers of 
endometrial stromal cells, and CD9 is a marker of epithelial cells [37,38]) and FACS to 
isolate uncultured single cells or cell populations from tissues. FACS methodology has 
previously been used to isolate specific cell types from endometrium of healthy women [39] 
and from endometrium of women suffering from endometriosis [26,40]. We have successfully 
isolated CD10-positive stromal cells from whole lesion biopsies [40] for transcriptomic study, 
indicating that this methodology can be successfully used to study endometriotic lesions. The 
current limitation of this methodology in endometriosis research is the shortage of specific 
antibodies to discriminate endometrial epithelial cells from lesion biopsy. For instance, anti-
CD10 antibody discriminates well CD10-negative cells ovarian stromal cells from 
endometrial CD10-positive cells stromal cells [38] but epithelial cell-specific anti-CD9 
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antibody that has been previously used for endometrial epithelial cell isolation [39] does not 
segregate ovarian CD9-positive cells granulosa cells [41] and epithelial cells from ectopic 
lesion. Also, it should be pointed out that beside endometrial epithelial and stromal cells, 
lesions contain also other cell types (endothelial cells etc.) that could have impact on disease 
pathogenesis. Therefore, computational methods that allow to infer cell-type specific 
expression profiles from whole-tissue samples, also known as gene expression profile 
deconvolution, can be used [42,43]. In conclusion, in spite of some shortcomings, these 
methodologies and ideas make it possible to move from highly heterogeneous whole-tissue 
approach to the cell type-specific approaches progressing endometriosis miRNA research to 
the next level.  
 
3. Moderate tissue/cellular heterogeneity - miRNA studies in endometrium  
Endometrium is a mixture of various cell types (e. g. stromal, epithelial, endothelial, immune 
cells) and the proportion of these cell types and the amount of blood vary in different 
endometrial biopsies, depending on the menstrual cycle phase and individual variability. Still, 
the cellular heterogeneity between endometrial samples from patients and controls is less 
pronounced than between endometrial and lesion biopsies, enabling to detect endometriosis-
associated changes more reliably. Indeed, previous molecular profiling studies in eutopic 
endometrium have suggested that gene expression alterations, that facilitate proliferation, 
implantation and survival of endometrial tissue in peritoneal cavity, exist in endometrial cells 
of endometriosis patients [44] supporting the theory that endometriosis pathogenesis may 
partially originate from altered eutopic endometrium. To understand the possible role of 
miRNAs from eutopic endometrium in endometriosis development, a number of hypothesis-
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driven and hypothesis-free studies have been performed. Hypothesis-driven studies focusing 
on single miRNAs have reported significantly lower expression of miR-199a [45], miR-126 
[46], miR-23a, miR-23b [12], miR-29c [13], miR-451 [47], higher expression of miR-202 
[48] and no significant changes of miR-143 and miR-145 [14] in endometrium of 
endometriosis patients compared to disease-free women (Table 3). Also, significantly higher 
levels of miR-135a and miR-135b were reported in eutopic endometrium of endometriosis 
patients; however, miR-135a was differentially expressed only in proliferative phase samples 
in patients with endometriosis compared to controls, indicating the impact of menstrual cycle 
phase on miRNA expression [49].  
During the recent years, some hypothesis-free high-throughput miRNA studies using 
endometrial tissue of patients and controls have also been performed [18,20,50–52], Table 3. 
It should be pointed out that the number of differentially expressed miRNAs (FC at least 1.5) 
has been relatively moderate (altogether 132 miRNAs, ranging from 6 - 69 per study), 
indicating that the overall differences between the endometrial miRNA signatures of patients 
and controls are rather insignificant. Moreover, if we compared the results of different studies, 
there were no miRNAs, which had been reported in at least three studies. Interestingly, some 
alternatively expressed miRNAs described in hypothesis-driven miRNA studies, such as miR-
23a, miR-23b, miR-29c and miR-145, have also been found to be altered in a microarray-
based study [50]. 
During the menstrual cycle, endometrium undergoes cyclic growth and degeneration 
and the levels of some miRNAs change along with the normal endometrial physiology. For 
example, the expression of miR-29b, miR-29c, miR-30b, miR-30d, miR-31, miR-193a-3p, 
miR-203, miR-204, miR-200c, miR-210, miR-582-5p and miR-345 was higher in secretory 
than in proliferative phase endometrial epithelial cells [53] and miR-181, miR-183 and miR-
200 family miRNAs were downregulated during the decidualization process [54]. 
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Additionally, some miRNAs (miR-30b, miR-30d, and miR-494) may participate in the 
regulation of endometrial receptivity [55]. Therefore, at least some variability described at 
miRNA level in endometrium of endometriosis patients could be caused by menstrual cycle 
fluctuations if samples from different phases have been analysed together (Table 3). 
Moreover, in some studies, the respective information about menstrual cycle phases of 
collected tissues is missing. 
To conclude, the question whether endometrial miRNAs contribute to the 
development of endometriosis has been tackled by many researchers, but the inconclusiveness 
and small overlap between the results of distinct studies suggests that either endometrial 
miRNA expression levels between patients and controls are relatively invariable and do not 
contribute to endometriosis development, or the differences in menstrual cycle phases, array 
platforms used, selection of patients and controls, data analysis and interpretation etc., mask 
the potentially important but minor changes in endometrial miRNA levels. Therefore, studies 
elucidating the role of miRNAs in regulation and function of normal endometrial physiology 
are warranted before any disease-related endometrial miRNAs can be found.  
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Table 3. Moderate tissue/cellular heterogeneity - miRNA studies comparing endometria from 
patients and controls  
 
Patients (n) Controls (n) 
Menstrual 
cycle phase* 
References 
Candidate miRNA studies 
miR-199a 12 12 P/S [45] 
miR-143, miR-145 13 22 P/S [14] 
miR-202 26 25 ND [48] 
miR-126 31 27 S [46] 
miR-23a, miR-23b 23 15 P [12] 
miR-29a, miR-29b, miR-29c 20 10 P [13] 
miR-135a, miR-135b 32 50 P/ES/MS/LS [49] 
miR-451 7 19 MS [47] 
High-throughput studies  
High-througput 
methodology 
Patients (n) Controls (n) 
Menstrual 
cycle phase* 
References 
miRCURY LNA microRNA 
Array, Exiqon 
10 11 P [50] 
TaqMan Array Human 
MicroRNA 
10 10 P [52] 
miRCURY LNA microRNA 
Array, Exiqon 
4 3 ES [51] 
miRCURY LNA microRNA 
Array, Exiqon 
3 3 ND [18] 
GeneChip miRNA 2.0 
Affymetrix array 
7 5 P/S [20] 
* P - proliferative, S - secretory, ES - early secretory, MS - mid secretory, ND - not 
determined. 
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4. Low tissue/cellular heterogeneity - miRNA studies in isolated and cultured cells 
The isolation of endometrial tissue-specific cells from lesions without any contamination of 
the surrounding tissue is a big challenge. The most widely used approach to obtain pure cells 
of interest is cell culturing that enables to isolate endometrial stromal and epithelial cell 
fractions with minimal contamination of other cells. However, this approach has its own 
limitations, such as cell culturing-induced expression alterations and difficulties in culturing 
primary endometrial epithelial cells. Furthermore, one issue that needs to be addressed in case 
of endometriomas is possible contamination of primary endometrial stroma cell cultures with 
ovarian stroma. There are no straightforward methodologies to evaluate the amount of ovarian 
stromal cells throughout the cell passages [56] and using cell cultures that include a mixture 
of endometrial and ovarian cells in unknown proportions may influence the results of 
transcriptomic studies. Still, the analysis of cultured primary stromal cell originating from 
endometrium (EnSC) or ectopic lesions (EcSC) could be a useful and valuable tool for 
miRNA studies offering the lowest cellular heterogeneity, as the same type of cells, 
irrespective of original location, are compared.  
To date, there is only one study comparing miRNA signatures of eutopic and ectopic 
stromal cells using high-throughput microarray approach. Twelve differentially expressed 
miRNAs were found [57], some of which were novel in the context of endometriosis (miR-
214, miR-445-3p, miR-210 and miR-181a), while most have previously been reported in 
whole-lesion biopsy or endometrium studies. For example, miR-196b [15,16,18,20], miR-100 
[15–17], miR-424-5p [15,20], miR-503, miR-199a-3p, miR-132* [16] were detected in 
whole-lesion biopsies and miR-29b [16,50,52] and miR-199b-5p [20,50] both in lesions and 
endometrium. However, as most of these miRNAs were not found to be dysregulated in 
endometrial tissues of endometriosis patients, it raises the question whether those expression 
differences precede lesion formation or are caused by the surrounding environment of 
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endometrial cells in ectopic location. Moreover, the endometrial expression levels of some of 
these miRNAs, such as miR-100, miR-424, miR-503 [58] and miR-199a [59] are influenced 
by the menstrual cycle phase. It can be hypothesised that the reason why these miRNAs were 
differentially expressed in lesions is hormonal dysregulation, as it is very likely that 
endometrial stromal cells in ectopic locations do not respond to hormonal changes in the same 
way as endometrial cells in uterus [60].  
A different approach to obtain pure cell populations was used in a very recent study in 
which miRNA profiles of both FACS-isolated stromal and epithelial cells from endometria of 
patients with and without endometriosis were analysed [26]. The analysis revealed clear 
clustering of microarray data: firstly, according to cell type (stromal and epithelial) and 
secondly, according to the disease status (control and endometriosis). However, only 9 and 16 
differentially expressed miRNAs were found in stromal and epithelial cells of patients 
compared to controls, respectively. Therefore, the analysis confirmed the results of whole 
endometrial tissue studies showing relatively few changes in endometrial miRNA expression 
levels in endometriosis. Interestingly, the most commonly described, miR-200b 
(downregulated in lesions) was found to be upregulated in stromal cells of endometriosis 
patients, and miR-375 (upregulated in whole-lesion biopsies) demonstrated lower expression 
in diseased epithelial cells [26]. Only two of these dysregulated miRNAs (miR-629 and miR-
3136) were previously mentioned in a study comparing whole endometrial tissues of women 
with or without endometriosis [50]. 
To summarize, the small number of differentially expressed miRNAs in EcSC 
compared to EnSC indicates that the overall signature of miRNAs is relatively similar in 
endometrial stromal cells regardless of the origin. However, it cannot be ruled out that cell 
culturing has an impact on gene expression levels and thus, some miRNA alterations between 
eutopic and ectopic stromal cells may not be detected, as during the culturing cells may 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
20 
 
undergo changes in transcriptomic profiles and lose their specific features. The transcriptome 
studies have shown that during cell culturing, a considerable shift in subpopulation dynamics 
will occur in response to in vitro growth conditions and thus the cell passaging may lead to 
selection pressure for specific cells inside the cell population (for example trypsine-sensitive 
cells, adherent cells, more active and proliferative cells etc.) that finally causes alterations in 
the overall transcription profile [61,62].  
 
5. Functional studies in eutopic and ectopic endometrial cells in endometriosis 
The most common application of EnSCs and EcSCs has been to explore the functions of 
miRNAs in stromal cells. Based on the function, studied miRNAs can be broadly divided into 
four categories: 1) miRNAs regulating apoptosis, 2) miRNAs involved in EMT, 3) miRNAs 
regulating cell proliferation, angiogenesis, invasion and viability and 4) miRNAs contributing 
to endometrial receptivity and infertility.  
5.1 miRNAs regulating apoptosis 
Properly functioning and strictly regulated apoptotic pathways are required to maintain 
organism homeostasis and therefore all abnormal fluctuations in this process could finally end 
up as potentially pathogenic. miRNAs are the key regulators of apoptosis by positive or 
negative regulation of anti- or pro-apoptotic mRNAs [63]. In endometriosis, the resistance to 
apoptosis has been considered as one possible cause why endometrial cells can survive in 
ectopic locations [64].  
One of the anti-apoptotic miRNAs, miR-183, was found to be downregulated in 
eutopic and ectopic endometrium of endometriosis patients compared to control endometrium 
[16,18,20]. As this miRNA also regulates many other important cellular processes that are 
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considered to be involved in endometriosis pathogenesis, such as cell growth, differentiation, 
motility, cell adhesion and invasion [65,66], the role of miR-183 has been explored in this 
context. Functional analysis confirmed that miR-183 plays a promotional role in EnSC 
apoptosis and negatively regulates the invasiveness of cells, although it had no effect on 
EnSC proliferation [18]. Further, Chen et al. [67] verified that integrin β1, a critical factor for 
cell adhesion and invasiveness, is a direct target gene of miR-183, and suggested that miR-
183 may have negative regulatory impact on cell invasiveness and overexpression of integrin 
β1 will block the repressive effects of miR-183 on EnSC invasiveness. Okamoto and 
colleagues [68] found that STAT3, an important regulator of several cellular processes, such 
as cell growth and apoptosis, was one of the key target molecules of miR-210. They 
suggested that anti-apoptotic miR-210 induces EnSCs to differentiate into the endometriotic 
phenotype, and that upregulation of miR-210 in EcSCs is involved in the formation of 
endometriosis-specific cellular dysfunctions [68]. miR-503 was found to be epigenetically 
repressed by hypermethylation in endometrial stroma cells from ovarian endometriotic 
tissues. Upregulation of miR-503 in these cells resulted in an inhibition of cell proliferation 
and induction of cell-cycle arrest at the G0/G1 phase through the suppression of cyclin D1, 
and the induction of apoptosis via suppression of the anti-apoptotic protein Bcl-2 [69]. 
The functional impact of anti-apoptotic miR-145 overexpression and inhibition on 
endometriotic cell behaviour and target gene expression was studied by Adammek et al. [29]. 
They showed that miR-145 inhibits endometriotic cell proliferation, invasiveness and 
stemness through regulation of cytoskeletal elements, cell adhesion molecules, proteolytic 
factors and pluripotency genes (FASCIN-1, JAM-A, SERPINE1, CT4, ACTG2, TAGLN, SOX2, 
KLF4, and PODXL). 
Additionally, studies of pro-apoptotic miRNAs have shown the involvement of miR-
195 and miR-29c in endometriosis pathogenesis. Higher expression of miR-195 in control 
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women EnSCs compared to patients’ EnSCs and EcSCs was shown, and cell-to-cell adhesion 
and communication facilitating FKN was identified as a functional target of miR-195 [70]. 
Furthermore, miR-195 inhibits the expression of survivin and MMP9, and therefore, the lower 
level of this miRNA in endometrial cells in endometriosis may enhance EcSC survival in the 
peritoneal cavity [70]. The studies of miR-29c function in endometriosis pathogenesis 
revealed that miR-29c directly affects specific extracellular matrix genes in ovarian 
endometriomas [17], and alteration in miR-29c level may lead to suppression of endometrial 
cell proliferation and invasion and promote cell apoptosis via negative regulation of c-Jun 
expression [13]. 
 
5.2 miRNAs regulating epithelial mesenchymal transition  
The dysregulation of miR-200 family (discussed in Section 2) in endometriotic lesions [8,15–
20] has been associated with higher migratory capacity of the cells, as during the EMT, the 
epithelial cells lose their epithelial features and acquire motile mesenchymal phenotype. In 
vitro upregulation of miR-200b in EnSCs resulted in downregulation of ZEB1 and ZEB2, and 
upregulation of E-cadherin, followed by decreased cellular invasiveness and motility [71]. In 
addition to regulating EMT and invasive cell behaviour, miR-200b upregulation in the 
endometriotic 12Z cell line also increased the expression of the transcription factor KLF4 and 
thereby enhanced endometrial cell proliferation and the stemness-associated side population 
phenotype in vitro [71]. 
In endometriosis, the role of miR-10b in EMT is still unknown, but it was shown in 
nasopharyngeal carcinoma cells that miR-10b regulates EMT through the KLF4/Notch1/E-
cadherin pathway, promoting cell migration and invasion [72]. Recently, it was demonstrated 
that miR-10b and its predicted target Syndecan-1 inhibit epithelial endometriotic cell 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
23 
 
invasiveness and viability through downregulation of metalloproteinase activity and IL-6 
secretion [73].  
5.3 miRNAs regulating cell proliferation, angiogenesis, invasion and viability 
Many functional studies in EnSCs have focused on the miRNAs participating in the 
regulation of cell proliferation, angiogenesis, invasion and cell viability. A whole biopsy 
study revealed that the expression level of miR-451 (designated also as miR-451a) was 
considerably higher in endometriotic lesions compared to eutopic endometrium and in inverse 
correlation with macrophage migration inhibitory factor (MIF) level [11]. As miR-451 and 
MIF are shown to be primarily expressed in endometrial epithelial cells [47,74] then to ensure 
that the expression level differences between lesions and endometrium are not the 
consequence of different number of epithelial cells in tissues, the expression level of epithelial 
cell-specific cytokeratin 18 was determined and confirmed to be similar in both investigated 
tissues [11]. Therefore, the functional role of miR-451 in reducing expression of MIF was 
confirmed in vitro in endometrial epithelial cell line and the forced expression of miR-451 
resulted not only in decreased MIF protein levels but also in reduced cell survival and 
proliferation. Authors proposed that the function of elevated miR-451 is to limit 
endometriotic lesion cell survival and on opposite, lesions expressing low levels of miR-451 
have higher potential to survive [11]. Interestingly, in vivo induction of endometriosis in 
baboons caused significant reduction in endometrial miR-451 level that in turn led to the 
increase in its target gene YWHAZ expression [47]. Further, inverse correlation between miR-
451 and YWHAZ expression was confirmed in vitro using epithelial cell lines and similarly to 
the previous study [11], overexpression of miR-451 inhibited cell proliferation [47]. However, 
in murine model of endometriosis, the low level of miR-451 was associated with a reduced 
ability of endometrial tissue to establish ectopically [75].  
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The higher expression of miR-202, previously associated with suppression of cell 
proliferation, migration and invasion in cancer studies [76], has also been reported in 
endometriotic lesions compared to endometria in whole tissue studies [16,18,20,48]. In a 
functional study, the high expression of miR-202 promoted cell proliferation and invasion 
through targeting transcription factor SOX6 and its downstream proteins [48].  
The important role of miR-142-3p in the regulation of cell viability and pro-
inflammatory signalling in EnSCs was shown using primary and immortalized EnSCs. This 
study confirmed that miR-142-3p upregulation causes significantly reduced expression of IL-
6 co-receptor gp130 and suggested that miR-142-3p downregulation in endometriosis might 
lead to the activation of JAK/STAT signalling pathway and increased cell viability [77].  
The role of angiogenesis in endometriosis pathogenesis is widely accepted, as 
neovascularization is needed for establishment of ectopic implants in peritoneal cavity. The 
dysregulation of some miRNAs, such as miR-15b, miR-16, miR-17-5p, miR-20a, miR-21, 
miR-125a, miR-221 and miR-222, that are shown to modulate the expression of pro-
angiogenic vascular endothelial growth factor A (VEGF-A) and anti-angiogenic 
Thrombospondin 1 (TSP-1), has been shown in whole biopsy study [9]. Also, there was a 
significant inverse correlation between miR-424-5p expression and VEGF-A protein level in 
eutopic endometrium of women with endometriosis and an inverse correlation between miR-
449b-3p and TSP-1 protein level in ovarian endometrioma [20]. To investigate whether 
VEGF-A expression is directly regulated by miR-16-5p, miR-29c-3p and miR-424-5p, as 
proposed by in silico analysis, primary stromal cells from endometrium of endometriosis 
patients and control women were transfected with respective miRNA mimics [78]. 
Interestingly, mimics transfection resulted in a significant down-regulation of VEGF-A 
protein level in a dose-dependent manner but did not affect VEGF-A mRNA expression, 
suggesting that these miRNAs mainly act as inhibitors of VEGF-A translation without 
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degrading respective mRNA. Furthermore, luciferase experiments demonstrated that VEGF-A 
3′ untranslated region (UTR) is a direct target of miR-29c-3p [78].  
 
The relevance of other miRNAs in angiogenesis and disease pathogenesis has also 
been confirmed in functional studies. For example, miR-20a is an interesting anti-apoptotic 
miRNA that was shown to be downregulated [9,15,16] or upregulated [79] in endometriotic 
lesion biopsies. A functional study confirmed that miR-20a upregulation in EcSCs is 
transcriptionally induced by HIF-1α and decreases the expression of its target protein DUSP2 
[79]. This, in turn, leads to aberrant ERK activation, ERK-regulated gene overexpression and 
PGE2-induced FGF9 expression. Because these genes play important roles in angiogenesis 
and stimulate both endothelial and endometrial cell proliferation, it was proposed that miR-
20a plays an important role in endometriosis pathogenesis [79]. The results from the 
functional study suggested that also miR-199a may attenuate the angiogenic potential of 
stromal cells under the hypoxia partly through HIF-1α/VEGF-A pathway suppression and 
thereby contribute to disease development [59]. Another study showed that elevated miR-
199a in ectopic endometrial mesenchymal stem cells suppressed cell proliferation, motility 
and angiogenesis by targeting the 3′ UTR of VEGF-A [80]. 
Interestingly, when considering miRNAs reported at least in three high-throughput 
studies, no overlapping miRNAs were found between all three study types and only miR-196b 
and miR-100 were common between low and high heterogeneity studies (Figure 2). A 
functional study in EcSCs proposed that overexpression of miR-196b causes downregulation 
of its target genes, a key regulator of cell proliferation c-myc and anti-apoptotic factor Bcl-2, 
leading to inhibition of endometrial cell proliferation and induction of apoptosis and mirroring 
the conditions in endometriotic lesions with low-level miR-196b and increased cellular 
proliferation [57]. Furthermore, there was a significant correlation between miR-196b and 
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HOXA10 expression and, thus, low miR-196b levels in endometriomas may stimulate 
proliferation, supress apoptosis and induce lesion growth. The antiangiogenic miR-100 has 
shown to function as an endogenous repressor of the serine/threonine protein kinase 
mammalian target of rapamycin (mTOR) and modulate proliferation, tube formation, and 
sprouting activity of endothelial cells and migration of vascular smooth muscle cells [81]. The 
roles of miR-196b and miR-100 in cellular processes, such as proliferation and apoptosis, as 
well as in tissue vascularization and wound healing, makes them attractive candidates that can 
easily be associated with endometriosis pathogenesis. 
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Figure 2. miRNAs and related biological processes reported in high-throughput miRNA 
studies in endometriosis. Figure denotes 14 miRNAs reported at least three times in high 
tissue/cellular heterogeneity studies (lesions compared to endometrium) and 12 miRNAs 
reported in a low tissue/cellular heterogeneity study (stromal cells from lesions compared to 
stromal cells from endometrium). ECM - extracellular matrix, EMT - epithelial-mesenchymal 
transition.  
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5.4 miRNAs regulating endometrial receptivity and infertility 
Functional studies in endometriosis have also concentrated on miRNAs such as miR-135a/b 
and miR-199a, previously linked with menstrual cycle regulation and implantation failure, 
and thus potentially related to endometriosis-associated infertility. 
The significant impact of menstrual cycle phase on miR-135a/b expression both in 
women with and without endometriosis was noticed by Petracco et al. [49]. It was shown that 
women with endometriosis have higher expression of miR-135a in proliferative phase 
endometrium, and higher miR-135b expression throughout the menstrual cycle compared to 
women without endometriosis. Furthermore, the authors showed that higher expression of 
miR-135a/b leads to downregulation of their target gene HOXA10 and thereby suppresses 
endometrial receptivity in endometriosis [49]. That, in turn, may be the cause of 
endometriosis-associated infertility, as HOXA10 has been proposed as one of the highly 
expressed genes in window of implantation [30]. Further, miR-199a has been linked with 
decreased endometrial receptivity and implantation defects in patients with endometriosis 
[45]. Transfection of endometrial cells with miR-199a repressed IκB kinase/NFκB signalling 
and inhibited IL-8 secretion, proposing that low expression of miR-199a upregulates 
inflammatory mediators leading to endometriosis-associated infertility [45].  
Taken together, the knowledge obtained from functional studies widens our 
understanding of miRNA-mediated processes in endometriosis pathogenesis and may 
facilitate the development of potential therapeutics for endometriosis treatment. Ideally, the 
function of every dysregulated miRNA in endometriosis should be clarified before proposing 
it as a disease-related molecule. However, it should be borne in mind that miRNAs are a part 
of a complex cellular system, so that each miRNA regulates simultaneously several genes 
and, moreover, in vivo levels of miRNAs may be regulated by various internal environment 
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factors that are not embodied in in vitro conditions. Therefore, in vitro obtained results should 
be extrapolated with caution to complex biological systems, such as endometriotic lesions in 
peritoneal cavity.   
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6. Future perspectives 
 
Based on the above-discussed contradictive findings, we suggest that future miRNA studies 
should focus on the isolation and analysis of specific cells from lesions and endometrium 
(discussed in Section 2.1) rather than analysing the miRNA signature of whole lesion 
biopsies.  
The large variability in tissue biopsy collection and characterization, specimen processing, 
and storage methodology, insufficient description of patient phenotypical data (e.g. missing 
data about menstrual cycle phase), small sizes of study groups and differences between 
miRNA detection methodologies, together with data analysis and interpretation differences, 
have created a situation where we still have no clear consensus on which miRNAs are 
involved in endometriosis pathogenesis. Thus, endometriosis studies need highly standardized 
sample collection recommendations, and large efforts to harmonize standard operating 
procedures for collecting both patients´ phenotypical data and tissue samples have already 
been made. World Endometriosis Research Foundation Endometriosis Phenome and 
Biobanking Harmonisation Project (WERF EPHect) has addressed the issues related to 
minimum and standard recommendations for data and sample collection emphasizing the 
importance of accompanying data registration during the tissue collection at laparoscopy [82–
84]. This data should include menstrual cycle characteristics, data on hormone treatment, 
history of previous endometriosis surgery, as well as any imaging findings before the 
procedure, the type and duration of the procedure; the extent, exact location, and colour of 
endometriotic lesions, and also video/photo documentation of surgery [84]. Only harmonised 
data/sample collection between different research centres will open new possibilities to 
perform well-powered large-scale international collaboration studies and to increase the 
liability of the reported findings.  
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Not only issues related to sample collection and documentation are fundamentally 
important to uncover the role of miRNAs in endometriosis pathogenesis but also proper data 
analysis should be emphasized, as even small differences in data processing and analysis may 
have an impact on the study results. For example, in endometriosis candidate-miRNA 
quantitative-PCR studies the most commonly used internal reference gene for expression 
data normalization is U6 small nuclear RNA (RNU6B). Although being stable under 
physiological and pathological conditions and abundantly expressed in tissues, the suitability 
of U6 as reference gene in miRNA studies has been lately questioned [85,86]. Furthermore, as 
the expression of endogenous controls may be tissue-dependent, the best strategy is to 
establish stable endogenous controls in a particular experimental design. For example, non-
coding RNAs (ncRNAs) RNU48, U75 and RNU44 were identified as stably and equivalently 
expressed between malignant and normal endometrial tissues while U6 was much less stable 
[87]. It may be argued that because of the larger size (approximately 200 bp), stability and 
processing efficiency of ncRNAs may differ from that of miRNAs; nevertheless, it has been 
shown that ncRNAs may perform as better endogenous controls than selected miRNAs [87]. 
Therefore, future studies should carefully consider the selection of best and optimal reference 
gene(s) as inappropriate normalization strategy may not only cause false association but leave 
small but significant changes in miRNA expression unnoticed [86].  
 
7. Conclusions  
The knowledge we have gathered from endometriosis miRNA studies suggests that the 
experimental design should be changed and should move from highly heterogeneous tissues 
to studies using specific cell populations. The methodology for obtaining pure fractions of 
cells from eutopic and ectopic endometrium without the need for cell culturing is already here 
(FACS, LCM) and constantly evolving, or as an alternative, computational methods as gene 
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expression profile deconvolution, can be used. Regardless of the approach chosen 
(experimental or computational), all different cell types (epithelial, stromal, immune cells) 
should be considered separately to reveal which specific cells are behind which particular 
aberrations, with the ultimate goal to uncover the molecular processes truly leading to 
formation of endometriotic lesions.  
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Highlights  
 Thus far, no consensus on which particular miRNAs are relevant in endometriosis 
 Endometriotic lesions have higher cellular heterogeneity compared to endometrium 
 Endometriosis-specific miRNAs could be masked by the tissue heterogeneity  
 Cell-type specific miRNA profiles of endometrium and lesions should be determined 
